Burges Salmon advises Genus plc on life sciences sector acquisition

The firm’s Corporate Finance team has advised Genus plc on its initial acquisition of the share capital of Xelect

17 September 2021

The Corporate Finance team from independent UK law firm Burges Salmon has advised world leading animal genetics company, Genus plc, on its partial acquisition of Xelect Limited, a globally recognised commercial aquaculture genetics and technology business, based in St Andrews, Scotland.

The multi-disciplinary Burges Salmon team that advised Genus on the transaction was led by Edinburgh-based partner Danny Lee and associate Katie Carter from the firm’s Corporate Finance team. They were supported by a range of colleagues from across the firm including Tax, Incentives, Intellectual Property, Employment and Real Estate.

Mark Birri, Strategy & Business Development Director states that: “The Burges Salmon team was instrumental in helping us navigate the transaction to completion and to promote warm relationships with the Xelect team and its advisors.

Danny comments: Through the transaction Genus gained R&D capabilities, helping them to assess the long-term opportunity in aquaculture genetics. This was a complex and interesting deal and we are pleased to have helped the Genus team through the process.”

Katie adds: “This deal further underlines the strength of our fast-growing Life Sciences and Biotech sector team.

Key contact

Danny Lee

Danny Lee Partner

  • Mergers and Acquisitions
  • Private Equity
  • Joint Ventures

Subscribe to news and insight

Burges Salmon careers

We work hard to make sure Burges Salmon is a great place to work.
Find out more